Sagefield Capital’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,000
Closed -$527K 169
2022
Q2
$527K Buy
+7,000
New +$527K 0.24% 67